PRESS RELEASE published on 08/11/2023 at 21:00, 1 year 3 months ago TTL Beteiligungs- und Grundbesitz-AG: TTL publishes 2023 half-year results
PRESS RELEASE published on 08/11/2023 at 19:16, 1 year 3 months ago EQS-Adhoc: TTL Beteiligungs- und Grundbesitz-AG: TTL adjusts forecast for financial year 2023
PRESS RELEASE published on 05/26/2023 at 12:44, 1 year 5 months ago TTL Beteiligungs- und Grundbesitz-AG: Annual General Meeting of TTL Beteiligungs- und Grundbesitz-AG approves stable dividend of EUR 0.20 per share
PRESS RELEASE published on 03/28/2023 at 08:30, 1 year 7 months ago TTL Beteiligungs- und Grundbesitz-AG: TTL publishes Annual Report 2022
Published on 11/22/2024 at 23:55, 9 hours 22 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 47 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 12 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 47 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 23 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 21 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 16 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
